Pyy hormone full name Peptide YY (PYY) is a fascinating gut hormone that plays a significant role in regulating appetite and influencing weight management. Emerging research suggests that PYY, particularly its PYY3-36 form, may be a key player in reducing appetite and contributing to weight loss, making it a target of interest for obesity therapies. Understanding how PYY functions can provide valuable insights into the complex interplay between our digestive system and overall body weight.作者：A De Silva·2012·被引用次数：467—This review article provides an overview of the centralcontrolof food intake and the role ofPYYand GLP-1 in appetitecontrol.
Peptide YY is released from specialized cells in the intestines in response to food intake, particularly fats and carbohydrates. Its primary mechanism of action involves signaling to the brain, specifically to the hypothalamus, a region critical for regulating hunger and satiety. By binding to receptors in the brain, PYY effectively communicates that the body is full, thereby reducing food intake and promoting feelings of fullness or satiety.
Studies have shown that administration of PYY3-36 can significantly decrease appetite and the amount of food consumed, both in animal models and in humans. This effect is crucial for preventing overeating and managing calorie intake, which are fundamental aspects of weight controlCombination Therapies:Using a mix of types of hormones, like GLP-1 or PYYalongside appetite control hormones could provide better outcomes, for weight loss .... Conversely, impaired secretion of PYY has been linked to an increased risk of obesity, as it may lead to reduced satiety and a tendency towards hyperphagia, or excessive eating.
The role of Peptide YY in appetite regulation has positioned it as a potential therapeutic target for obesity. Research indicates that PYY levels can be influenced by various factors, including diet and surgical interventions. For instance, individuals who have undergone gastric bypass surgery often show elevated PYY levels post-operation, which is thought to contribute to the significant weight loss observed in these patientsInhibition of Food Intake in Obese Subjects by Peptide YY3 ....
Furthermore, the administration of PYY or its analogues has been explored as a strategy for weight reduction. Some studies have demonstrated that PYY administration can lead to a decrease in body weight, with certain treatment regimens showing notable weight loss percentages. The efficacy of PYY as a weight loss agent is often discussed in conjunction with other gut hormones like GLP-1 (Glucagon-like peptide-1), with combination therapies showing promising results作者：KS Chichura·2023·被引用次数：22—Peripheral administration of PYY3-36reduces caloric intake, increases postprandial insulin levels, and enhances insulin sensitivity, .... For example, a combination of PYY analogues with drugs like semaglutide has led to greater weight loss compared to semaglutide alone.
Several factors can influence circulating levels of Peptide YY. Fasting typically leads to decreased PYY levels, while eating, especially meals rich in fats and proteins, stimulates its release. This dynamic fluctuation helps the body to signal hunger when fasting and satiety after mealsCritical role for peptide YY in protein-mediated satiation ....
Interestingly, certain dietary components, such as oligofructose, have been shown in rodent studies to promote weight loss by stimulating the secretion of satiety hormones like PYY, reducing energy intake, and improving lipid profilesPulmonary delivery of peptide YY for food intake suppression .... This highlights the potential for dietary interventions to modulate PYY levels and support weight management goals.
However, it's important to note that the effectiveness and long-term implications of PYY-based therapies are still areas of active research. Some findings suggest that prolonged or repeated administration of PYY might lead to desensitization, potentially hindering consistent effects on feeding and weight loss. Ongoing research continues to investigate optimal delivery methods and therapeutic strategies to harness the weight-loss potential of PYY effectively and safely.
Peptide YY often works in concert with other hormones involved in appetite regulation, most notably GLP-1. Both hormones are released from the gut in response to food and act on the brain to reduce appetite and increase feelings of fullnessPeptide YY Therapy for Obesity. Their synergistic action makes them attractive targets for developing comprehensive obesity treatments.
While elevated PYY levels are associated with reduced appetite and weight loss, paradoxically, high concentrations of PYY have also been observed in conditions characterized by dramatic weight loss, such as anorexia nervosa and celiac diseaseThe role of peptide YY in appetite regulation and obesity - PMC. This underscores the complexity of hormonal regulation and the need for further research to fully elucidate PYY's multifaceted roles in various physiological states作者：A De Silva·2012·被引用次数：467—This review article provides an overview of the centralcontrolof food intake and the role ofPYYand GLP-1 in appetitecontrol..
In conclusion, Peptide YY is a critical gut hormone that significantly influences appetite and satiety signals sent to the brainPeptide YY (PYY): A Key Regulator of Appetite and .... Its potential as a therapeutic agent for weight loss and obesity management is a promising area of scientific inquiry, with ongoing research exploring its mechanisms of action, optimal delivery, and synergistic effects with other hormones. Understanding the role of PYY provides valuable insight into the intricate biological processes that govern our eating behaviors and body weight.Peptide YY and Glucagon-like Peptide-1 Secretion in Obesity
Join the newsletter to receive news, updates, new products and freebies in your inbox.